Cargando…
PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers
Poly[adenosine diphosphate (ADP) ribose]polymerase (PARP) has multifaceted roles in the maintenance of genomic integrity, deoxyribonucleic acid (DNA) repair and replication, and the maintenance of immune-system homeostasis. PARP inhibitors are an attractive oncologic therapy, causing direct cancer c...
Autores principales: | Lee, Elizabeth K., Konstantinopoulos, Panagiotis A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383615/ https://www.ncbi.nlm.nih.gov/pubmed/32782491 http://dx.doi.org/10.1177/1758835920944116 |
Ejemplares similares
-
Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020) -
Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021) -
A rapidly evolving landscape: immune checkpoint inhibitors in
pretreated metastatic endometrial cancer
por: Tinker, Anna V., et al.
Publicado: (2023) -
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
por: Ding, Liya, et al.
Publicado: (2023) -
Immunotherapy as a treatment strategy in advanced stage and recurrent
endometrial cancer: review of current phase III immunotherapy clinical
trials
por: Eskander, Ramez N., et al.
Publicado: (2021)